Print Page  Close Window


Corporate Profile

Founded in 2006, Ocular Therapeutix, Inc. (NASDAQ:OCUL) is focused on the development, commercialization, and manufacturing of innovative ocular therapies using its HYDROME(TM) technology. Our product pipeline candidates utilize our platform to provide differentiated drug delivery solutions that are designed to greatly reduce the complexity and burden of current drop of injection regimens by creating sustained release, one-time or several-month dosage forms. The sustained release of these dru... More >>

Stock QuoteMore >>
OCUL (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.04 (0.69%)
Data as of 08/17/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Investor EventsMore >>
There are currently no events scheduled.
Industry EventsMore >>
There are currently no events scheduled.
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Ocular Therapeutix, Inc. posts new information to the site.
Just enter your e-mail address and click Submit.
Data provided by Nasdaq. Minimum 15 minutes delayed.